Erratum to: Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers.

Carlier, Patrick; Markarian, Maritza; Bernard, Nathalie; Lagarce, Laurence; Dautriche, Anne; Béné, Johanna; Sam-Lai, Nathalie Fouilhe; Eftekhari, Pirayeh

Carlier, Patrick; Markarian, Maritza; Bernard, Nathalie; Lagarce, Laurence; Dautriche, Anne; Béné, Johanna; Sam-Lai, Nathalie Fouilhe; Eftekhari, Pirayeh.

Afiliação

Carlier P; Centre régional de Pharmacovigilance, Hôpital Fernand-Widal, AP-HP, Paris, France. pharmacovigilance.fwd.lrb@aphp.fr.
Markarian M; Centre régional de Pharmacovigilance, Hôpital Fernand-Widal, AP-HP, Paris, France.
Bernard N; Centre régional de Pharmacovigilance, Hospices Civils de Lyon, Lyon, France.
Lagarce L; Centre régional de Pharmacovigilance, CHRU Angers, Angers, France.
Dautriche A; Centre régional de Pharmacovigilance, CHU Dijon, Dijon, France.
Béné J; Centre régional de Pharmacovigilance du Nord Pas de Calais, CHU Lille, 59000, Lille, France.
Sam-Lai NF; Centre régional de Pharmacovigilance, CHU Grenoble Alpes, Grenoble, France.
Eftekhari P; Centre régional de Pharmacovigilance, Hôpital Fernand-Widal, AP-HP, Paris, France.

Arch Gynecol Obstet ; 295(4): 1059, 2017 04.

Article em En | MEDLINE | ID: mdl-28255764

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article